Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,452 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Leukoencephalopathy caused by a 17p13.3 microdeletion.
Wade C, Williams T, Labrum R, Patel Y, Cali E, Davagnanam I, Adams ME, Barkhof F, Murphy E, Chataway J, Houlden H, Lynch DS. Wade C, et al. Among authors: barkhof f. J Neurol Neurosurg Psychiatry. 2024 Feb 14;95(3):290-292. doi: 10.1136/jnnp-2023-331986. J Neurol Neurosurg Psychiatry. 2024. PMID: 37734926 Free article. No abstract available.
Networks of microstructural damage predict disability in multiple sclerosis.
Colato E, Prados F, Stutters J, Bianchi A, Narayanan S, Arnold DL, Wheeler-Kingshott C, Barkhof F, Ciccarelli O, Chard DT, Eshaghi A. Colato E, et al. Among authors: barkhof f. J Neurol Neurosurg Psychiatry. 2023 Dec;94(12):992-1003. doi: 10.1136/jnnp-2022-330203. Epub 2023 Jul 19. J Neurol Neurosurg Psychiatry. 2023. PMID: 37468305
Longitudinal Metabolite Changes in Progressive Multiple Sclerosis: A Study of 3 Potential Neuroprotective Treatments.
John NA, Solanky BS, De Angelis F, Parker RA, Weir CJ, Stutters J, Carrasco FP, Schneider T, Doshi A, Calvi A, Williams T, Plantone D, Monteverdi A, MacManus D, Marshall I, Barkhof F, Gandini Wheeler-Kingshott CAM, Chataway J; MS‐SMART Investigators. John NA, et al. Among authors: barkhof f. J Magn Reson Imaging. 2024 Jun;59(6):2192-2201. doi: 10.1002/jmri.29017. Epub 2023 Oct 3. J Magn Reson Imaging. 2024. PMID: 37787109 Clinical Trial.
Improving explanation of motor disability with diffusion-based graph metrics at onset of the first demyelinating event.
Foster MA, Prados F, Collorone S, Kanber B, Cawley N, Davagnanam I, Yiannakas MC, Ogunbowale L, Burke A, Barkhof F, Wheeler-Kingshott CAG, Ciccarelli O, Brownlee W, Toosy AT. Foster MA, et al. Among authors: barkhof f. Mult Scler. 2024 Jun;30(7):800-811. doi: 10.1177/13524585241247785. Epub 2024 May 15. Mult Scler. 2024. PMID: 38751221 Free PMC article.
Updating the study protocol: Insight 46 - a longitudinal neuroscience sub-study of the MRC National Survey of Health and Development - phases 2 and 3.
Murray-Smith H, Barker S, Barkhof F, Barnes J, Brown TM, Captur G, R E Cartlidge M, Cash DM, Coath W, Davis D, Dickson JC, Groves J, Hughes AD, James SN, Keshavan A, Keuss SE, King-Robson J, Lu K, Malone IB, Nicholas JM, Rapala A, Scott CJ, Street R, Sudre CH, Thomas DL, Wong A, Wray S, Zetterberg H, Chaturvedi N, Fox NC, Crutch SJ, Richards M, Schott JM. Murray-Smith H, et al. Among authors: barkhof f. BMC Neurol. 2024 Jan 23;24(1):40. doi: 10.1186/s12883-023-03465-3. BMC Neurol. 2024. PMID: 38263061 Free PMC article.
Towards cascading genetic risk in Alzheimer's disease.
Altmann A, Aksman LM, Oxtoby NP, Young A; ADNI; Alexander DC, Barkhof F, Shoai M, Hardy J, Schott JM. Altmann A, et al. Among authors: barkhof f. Brain. 2024 May 31:awae176. doi: 10.1093/brain/awae176. Online ahead of print. Brain. 2024. PMID: 38820112
Disease progression in dementia with Lewy bodies: A longitudinal study on clinical symptoms, quality of life and functional impairment.
van de Beek M, van Unnik A, van Steenoven I, van der Zande J, Barkhof F, Teunissen CE, van der Flier W, Lemstra AW. van de Beek M, et al. Among authors: barkhof f. Int J Geriatr Psychiatry. 2022 Nov 12;37(12):10.1002/gps.5839. doi: 10.1002/gps.5839. Online ahead of print. Int J Geriatr Psychiatry. 2022. PMID: 36403133 Free PMC article.
Vitamin D did not reduce multiple sclerosis disease activity after a clinically isolated syndrome.
Butzkueven H, Ponsonby AL, Stein MS, Lucas RM, Mason D, Broadley S, Kilpatrick T, Lechner-Scott J, Barnett M, Carroll W, Mitchell P, Hardy TA, Macdonell R, McCombe P, Lee A, Kalincik T, van der Walt A, Lynch C, Abernethy D, Willoughby E, Barkhof F, MacManus D, Clarke M, Andrew J, Morahan J, Zhu C, Dear K, Taylor BV; PREVANZ Investigators. Butzkueven H, et al. Among authors: barkhof f. Brain. 2024 Apr 4;147(4):1206-1215. doi: 10.1093/brain/awad409. Brain. 2024. PMID: 38085047 Free PMC article. Clinical Trial.
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical Trial.
Altomare D, Barkhof F, Caprioglio C, Collij LE, Scheltens P, Lopes Alves I, Bouwman F, Berkhof J, van Maurik IS, Garibotto V, Moro C, Delrieu J, Payoux P, Saint-Aubert L, Hitzel A, Molinuevo JL, Grau-Rivera O, Gispert JD, Drzezga A, Jessen F, Zeyen P, Nordberg A, Savitcheva I, Jelic V, Walker Z, Edison P, Demonet JF, Gismondi R, Farrar G, Stephens AW, Frisoni GB; Amyloid Imaging to Prevent Alzheimer’s Disease (AMYPAD) Consortium. Altomare D, et al. Among authors: barkhof f. JAMA Neurol. 2023 Jun 1;80(6):548-557. doi: 10.1001/jamaneurol.2023.0997. JAMA Neurol. 2023. PMID: 37155177 Free PMC article. Clinical Trial.
1,452 results